Artificial insemination is a medically assisted fertilization process, which involves introducing the semen sample into the female's reproductive tract for conception. It helps single mothers, same-sex couples, or infertile heterosexual couples to have children without sexual intercourse. The procedure avoids the risks and costs associated with multiple implantations or complex fertility treatments. It has emerged as a preferred alternative to natural conception or other assisted reproductive technologies like IVF that often require surgery.
Market key trends:
The growing preference for procedures without surgery is one of the key trends driving the growth of artificial insemination market. Artificial insemination does not require surgery and complex implantation procedures like IVF treatments. It is a simpler and more natural procedure compared to IVF and other advanced fertility treatments. This advantages have increased its acceptance among consumers. Furthermore, the non-invasive nature and avoidance of surgery related risks have accelerated the demand for artificial insemination globally.
Segment Analysis
The global artificial insemination market is segmented by technology into intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination segment dominates the market and accounts for around 60% share globally due to its higher success rate compared to other technologies. Intrauterine insemination allows placement of sperm directly into the uterus which provides easier access to the fallopian tubes and higher chances of conception.
Key Takeaways
Global Artificial Insemination Market Size is expected to witness high growth over the forecast period of 2023 to 2030 supported by an increasing prevalence of infertility worldwide.
Regional analysis: North America dominates the global artificial insemination market currently holding around 35% share due to established healthcare infrastructure, growing prevalence of infertility, and rising focus on family planning among individuals in the region. Asia Pacific is expected to witness fastest growth during the forecast period owing to growing medical tourism, increasing healthcare spending, and rising fertility clinics in major countries like India and China.
Key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. These players are focused on expanding their product portfolios and presence in developing regions through acquisitions and collaborations with hospitals and fertility clinics.
Explore More Related Article On This Topic: https://www.ukwebwire.com/artificial-insemination-market-trends/
Explore More Related Article On This Topic: https://www.newsintv.com/news/offshore-the-decommissioning-a-best-growing-sector/
Comments
0 comment